Toshiyuki Fukazawa

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

A Retrospective Study of 116 Multiple Sclerosis Patients with Dimethyl Fumarate Treatment in a Single Institution in Japan.

A Retrospective Study of 116 Multiple Sclerosis Patients with Dimethyl Fumarate Treatment in a Single Institution in Japan.

Journal: Internal medicine (Tokyo, Japan)
Published: November 26, 2025

Three cases of multiple sclerosis presenting with palmoplantar pustulosis while receiving ofatumumab.

Three cases of multiple sclerosis presenting with palmoplantar pustulosis while receiving ofatumumab.

Journal: Journal of the neurological sciences
Published: September 21, 2024

A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: The REFIND study.

A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: The REFIND study.

Journal: Multiple sclerosis and related disorders
Published: March 19, 2024

FGF14 GAA repeat expansion and ZFHX3 GGC repeat expansion in clinically diagnosed multiple system atrophy patients.

FGF14 GAA repeat expansion and ZFHX3 GGC repeat expansion in clinically diagnosed multiple system atrophy patients.

Journal: Journal of neurology
Published: January 11, 2024

Seasonal fluctuations in serum levels of vitamin D in Japanese patients with multiple sclerosis.

Seasonal fluctuations in serum levels of vitamin D in Japanese patients with multiple sclerosis.

Journal: Journal of neuroimmunology
Published: February 25, 2021

Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis.

Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis.

Journal: Internal medicine (Tokyo, Japan)
Published: May 01, 2018

Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.

Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.

Journal: PloS one
Published: January 16, 2018

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan.

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan.

Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: September 04, 2017

Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis.

Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis.

Journal: Clinical immunology (Orlando, Fla.)
Published: April 19, 2017

Once-daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing-remitting multiple sclerosis.

Once-daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing-remitting multiple sclerosis.

Journal: Clinical & experimental neuroimmunology
Published: December 14, 2016

The dynamics of mucosal-associated invariant T cells in multiple sclerosis.

The dynamics of mucosal-associated invariant T cells in multiple sclerosis.

Journal: SpringerPlus
Published: May 22, 2016

Fingolimod suppresses bone resorption in female patients with multiple sclerosis.

Fingolimod suppresses bone resorption in female patients with multiple sclerosis.

Journal: Journal of neuroimmunology
Published: March 31, 2016
Showing 1-12 of 27

Last Updated: 09/26/2026